Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Prospective, Multicenter, Single-arm, Open-label, Phase 4 Study to Evaluate the Effects of Macitentan on Right vEntricular Remodeling in Pulmonary ArterIal hypeRtension Assessed by Cardiac Magnetic Resonance Imaging

Trial Profile

A Prospective, Multicenter, Single-arm, Open-label, Phase 4 Study to Evaluate the Effects of Macitentan on Right vEntricular Remodeling in Pulmonary ArterIal hypeRtension Assessed by Cardiac Magnetic Resonance Imaging

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 06 Nov 2021

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Macitentan (Primary) ; Type 5 cyclic nucleotide phosphodiesterase inhibitors
  • Indications Pulmonary arterial hypertension
  • Focus Therapeutic Use
  • Acronyms REPAIR
  • Sponsors Actelion Pharmaceuticals
  • Most Recent Events

    • 17 May 2021 Results of an analysis assessing the compare standardized treatment effect sizes (STES) of cMRI, hemodynamic and functional endpoints presented at the 70th Annual Scientific Session of the American College of Cardiology
    • 21 Oct 2020 Results from REPAIR ECHO substudy presented at the CHEST Annual Meeting 2020 by Annual Meeting of the American College of Chest Physicians
    • 24 Sep 2020 Results published in the ClinicalTrials.gov Trial Registry

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top